Major brain mapping study reveals gene activity patterns across lifespan

Researchers have completed one of the most detailed maps ever made of how the human brain changes over a lifetime, tracking the activity of genes in individual cells of the prefrontal cortex from childhood through old age. The work, published in Nature and led by scientists at Mount Sinai, reveals that the brain does not age gradually or uniformly. Instead, it undergoes two distinct shifts—one around age 24 and another around age 60—when the molecular machinery of brain cells reorganizes in measurable ways.

The prefrontal cortex, the region behind the forehead responsible for decision-making, impulse control, and complex reasoning, is where much of what makes us distinctly human happens. Until now, scientists understood this region's basic anatomy but had only fragmentary knowledge of how the genes that build and maintain it behave across decades. The new atlas changes that. Researchers used single-nucleus transcriptomics—a technique that reads which genes are active in individual cell nuclei—to profile brain tissue from donors at different life stages. The result is a molecular portrait of the prefrontal cortex that shows not just which genes turn on and off, but when and in which types of cells those changes occur.

The discovery of two major transition points is striking because it suggests the brain is not simply wearing down with age. At 24, when most people are finishing education and entering adult life, the prefrontal cortex undergoes a significant molecular reorganization. Gene activity patterns shift. The cells that make up this region reconfigure their molecular priorities. Then, for decades, the brain maintains relative stability. But around 60, another major transition occurs. The molecular landscape shifts again, and the patterns of gene activity change substantially. These are not subtle variations—they are coordinated, system-wide changes in how the brain's cells operate.

The implications for understanding disease are substantial. The researchers connected specific patterns of gene activity to various brain disorders, including conditions that affect cognition, mood, and behavior. By identifying which molecular signatures appear in disease states, scientists now have a roadmap for understanding how normal aging and disease diverge at the molecular level. A gene that is active in healthy 50-year-olds might be silent in people with a particular psychiatric condition at the same age. That difference—that molecular signature—becomes a target for investigation and potentially for treatment.

Mount Sinai's team published nine coordinated studies as part of this effort, each examining different aspects of the brain's molecular and cellular architecture. Together, they form a resource that other researchers can use to ask new questions about why certain disorders emerge at certain ages, why some people are resilient to cognitive decline while others are not, and how the brain's molecular state at one point in life influences its vulnerability to disease later. The atlas is not a finished answer but a foundation—a detailed map that makes it possible to see patterns that were invisible before.

The work points toward a future in which treatments for neurological and psychiatric conditions could be tailored to a person's age and the specific molecular state of their brain cells. Rather than using a single drug for all patients with a condition, clinicians might eventually use molecular signatures to identify which patients would benefit from which therapies. A 30-year-old and a 70-year-old with the same diagnosis might have very different gene activity patterns in their prefrontal cortex, and thus might need different approaches. The atlas makes that kind of precision possible by showing, in unprecedented detail, what normal molecular variation looks like across the human lifespan.